White House: Delay in FDA's Moderna review won't impact pediatric vaccine rollout | The Hill: Healthcare Policy

The delay in the Food and Drug Administration’s (FDA) review of the Moderna COVID-19 vaccine for adolescents won’t impact the Biden administration’s vaccine rollout for children, White House officials said on Monday.With the White House preparing...